ANNX Share Price Performance
SEK 13.50
-20.20 (-59.94%)
Price SEK 13.50
Share Pricen/a
Annexin Pharmaceuticals AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
ANNX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Annexin Pharmaceuticals AB (publ) Key Details
About ANNX
- Founded
- 2014
- Employees
- 4
- CEO
- WebsiteView website
Annexin Pharmaceuticals AB (publ), a clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein and Annexin A5, natural protein that protects and repairs cells, as well as counteract unwanted inflammatory and immune cell reactions. Annexin Pharmaceuticals AB (publ) was incorporated in 2014 and is based in Stockholm, Sweden.
